Medical cannabis and its effect on oncological outcomes in patients with ovarian cancer treated with PARP inhibitors | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

other Versions

View the most recent version of this article
You are currently viewing an earlier version of this article (April 01, 2024).

Original research

Medical cannabis and its effect on oncological outcomes in patients with ovarian cancer treated with PARP inhibitors

Online download statistics by month:

Online download statistics by month: January 2024 to September 2024

	Abstract	Full	Pdf
Jan 2024	916	28	12
Feb 2024	444	13	10
Mar 2024	228	6	5
Apr 2024	559	29	17
May 2024	227	16	13
Jun 2024	467	5	5
Jul 2024	417	2	2
Aug 2024	107	5	1
Sep 2024	86	0	0
Total	3451	104	65